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A B S T R A C T
The aim of this research was to perform the nutritional screening and clinical assessment of malnutrition and of
cachexia as well as the need for enteral nutritional support. We used an international questionnaire for nutrition screen-
ing and clinical assessment of malnutrition. 103 cancer patients participated in the research. The results indicate that
80 patients (78%) have recently unintentionally lost weight in the last six months. Of those 80 patients 12 (15%) have lost
more than 15 kilograms. Three patients (3%) suffer from hunger because of their inability to eat. Presence of multiple (3
or more) symptoms (nausea, vomiting, diarrhea or anorexia) was reported by 11 patients (11%). Severe work dysfunction
was found in 28 patients (27%). 14 patients (14%) experience significant loss of musculature (musculus quadriceps
femoris, musculus deltoideus). The obtained results indicate that 15 patients (14%) are severely, and 39 patients (38%)
are moderately undernourished. This survey confirmed the significance of nutritional screening in cancer patients, as it
detected 30 patients (29%) who required introduction of enteral nutrition.
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Introduction
Cancer is the second leading cause of death in high in-
come countries of the world as well as in Croatia and it is
considered that every fourth person dies of it1. In Croatia
according to our national cancer registry in 2009 there
were 21199 new cancer cases (the incidence and mortal-
ity statistics includes all invasive types of cancer except
skin cancer) and 13315 people died of it1. Same year
nearly 12.7 million new cancer cases and 7.6 million can-
cer deaths occurred worldwide2.
Malnutrition and cachexia are most commonly seen
in cancer patients with some types of solid tumors, vari-
ous chronic diseases, as well as in older persons and
young children3–7. One of the most important contribu-
tors to cancer related mortality are malnutrition and
cachexia, also referred to as anorexia-cachexia syndrome.
While term »malnutrition« simply stands for condition of
energy, protein and/or nutritive deficiency, »cachexia« (or
wasting syndrome) is well defined clinical condition char-
acterized by loss of weight, muscle atrophy, fatigue,
weakness, impaired performance status and significant
loss of appetite in someone who is not actively and con-
sciously trying to lose weight. In majority of cases, cache-
xia is accompanied with anorexia (loss of appetite) and
malnutrition. Presence of one or both nutritive deficien-
cies have negative influence on treatment duration and
outcome, number and severity of complications, length of
hospital stay, treatment costs, quality of life and mortal-
ity rate3–7.
Presence of malnutrition and especially cachexia should
always induce suspicion of malignant growth. Tumors of
the upper gastrointestinal tract and lung are most fre-
quently associated with weight loss5–7.
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Besides cachexia, malnutrition is a common problem
in cancer patients as well as a problem of chronic and in-
curable diseases. However, the problem of malnutrition
and cachexia can be reduced by a well-timed assessment
followed by an adequate nutritional intervention. Opti-
mal approach is introduction of early initial nutritional
assessment of cancer patients, conduction of further reg-
ular nutritional screening and possible initiation of nu-
tritive support in order to prevent further deterioration
and negative effects on disease outcome4,6,8–10.
The simplest way for early recognition of malnutri-
tion and cachexia is to carry out the assessment of nutri-
tional status as a routine method for all patients who are
in an increased risk of malnutrition and cachexia. The
aim of such assessment is to introduce an adequate nu-
trition intervention on time8,10,11.
The aim of our study was:
1. To carry out nutrition screening and clinical assess-
ment of malnutrition in patients suffering from malig-
nant diseases using Malnutrition Screening Tool (MST)
and Global Assessment (SGA) questionnaires.
2. Determine the presence of malnutrition and ca-
chexia in cancer patients treated at their home, after
they underwent hospital oncological treatment, as well
as category (severity) of malnutrition based on personal
history, physical examination, amount of lost weight,
presence of gastrointestinal symptoms, functional status
and amount of fat and muscle tissue loss.
3. Determine the necessity for enteral nutritional
support introduction adapted for the needs of cachectic
cancer patients.
Patients and Methods
In the study we used MST (Malnutrition Screening
Tool) – an international questionnaire for nutritive scre-
ening of cancer patients12 and SGA (Subjective Global
Assessment) – a questionnaire for clinical assessment of
malnutrition in patients suffering from malignant di-
seases13,14. The questionnaire was approved by Croatian
Society of Oncology and Croatian Society of Parenteral
and Enteral Nutrition15. The MST questionnaire con-
sists of three questions for nutritive screening of cancer
patients, on the basis of which a diagram of further pro-
cedures is made (new screening, nutritive assessment or
introducing enteral nutrition). SGA questionnaire esti-
mates nutritional status of patients with malignant dis-
ease based on personal history information and physical
examination. With further data analysis nutritional sta-
tus of each examinee is individually determined.
As a support to statistical calculations and data analy-
sis software package SPSS Statistic 17.0.
The research was carried out by nurse visits from
Health Centre Osijek who interviewed cancer patients
treated at their home, after they underwent hospital
oncological treatment). The research included 103 can-
cer patients who live in the Osijek Health centre area; 48
(47%) men and 55 (53%) women and it was done in the
second half of the year 2011. Median age of the patients
was 64.96 years (range 48–77 years).
Results
In the last six months 80 patients out of 103 (78%)
have experienced unintentional loss of weight and 23
(22%) patients maintained their usual body mass. The
percentages reached statistical significance (c2=31.544,
p=0.000, df=1).
Furthermore, 60 patients (58%) state that they have
been eating poorly because of a decreased appetite and 43
patients (42%) have not experienced changes in their ap-
petite.
Of 80 patients who experienced weight loss, 12 pati-
ents (15%) have lost more than 15 kilograms, 19 patients
(23%) lost between 11 and 15 kilograms, 24 patients
(30%) lost between 6 and 10 kilograms and 25 patients
(32%) have lost 5 kilograms or less (Table 1).
After nutritional screening, 30 patients (30%) had
MST score (weight loss and decreased appetite) of 4–5 (it
is necessary to introduce enteral nutrition), 37 patients
(35%) had MST score 2–3 (further clinical assessment of
malnutrition is carried out), while 36 patients (35%) had
MST score 0–1 (which requires repeated screening) (Ta-
ble 2).
Subjective Global Assessment (SGA) questionnaire
has established that 29 patients (28%) suffer from weight
loss of more than 10%, in 24 patients (23%) weight loss
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TABLE 1
QUANTIFICATION (AMOUNT) OF WEIGHT LOSS IN THE LAST
SIX MONTHS




















1 17 17 New screening required
0 19 18
Total 103 100
was 5–10%, while 50 patients (49%) did not have signifi-
cant weight loss (Table 3).
3 patients (3%) experience hunger because they can-
not eat, 43 patients (42%) have meager food intake with
improvements or borderline food intake with deteriora-
tion, and 57 patients (55%) do not have any significant
changes in their food intake (Table 4).
11 patients (11%) have daily presence of 3 or more
symptoms (nausea, vomiting, diarrhea or anorexia) that
lasted at least 2 weeks, 37 patients (36%) have 1 or 2 of
those symptoms and 55 patients (53%) did not experi-
ence any of the mentioned symptoms (Table 5).
28 patients (27%) suffer from severe work dysfunc-
tion as well as dysfunction in activities of daily living, 40
patients (39%) have a mild dysfunction while 35 patients
(34%) maintained normal work and everyday function-
ing. Altogether, 66% of the patients suffer from (mild or
severe) dysfunction at their workplace and/or in activi-
ties of daily living, which showed statistical significance
(c2=2.117, p=0.347, df=2) (Table 6).
23 patients (22%) have high nutritive demands due to
complications of the primary disease (inflammation, di-
arrhea, vomiting etc.), in 35 patients (34%) demands are
low to moderate, while in 45 patients (44%) no increase
in nutritive demands was observed (Table 7).
In order to determine the status of musculature and
subcutaneous fat tissue, clinical evaluation was carried
out, according to the guidelines (quoted) at the end of the
questionnaire. 14 patients (13%) experienced severe sub-
cutaneous fat loss in m. triceps brachii and chest area
and in 41 patients (40%) there were only mild to moder-
ate changes in the test results and in 48 patients (47%)
the results were no abnormality detected (NAD).
14 patients (14%) had severe loss of muscle tissue, in
38 patients (37%) the loss of musculature was mild to
moderate, while in 51 patients (49%) muscle loss wasn’t
observed (the results are NAD) (Table 8).
6 patients (6%) have severe perimalleolar edema; mild
to moderate presence of perimalleolar edema has been
established in 19 patients (18%) and in 78 patients (76%)
the results were NAD. Number of patients without ede-
ma is statistically significantly higher compared to the
number of patients with perimalleolar and presacral
edema and ascites (Chi-squared (c2=85.767, p=0.000,
df=2).
Based on the obtained results it has been established
that 15 patients (14%) are severely undernourished (SGA
C), 39 patients (38%) are moderately undernourished
(SGA B), while 49 patients (48%) are well-nourished
(SGA A) (Table 9).
B. Ebling et al.: Nutritional Status in Cancer Patients, Coll. Antropol. 38 (2014) 1: 105–110
107
TABLE 5
PRESENCE OF EVERYDAY SYMPTOMS IN DURATION




No symptoms 55 53
1–2 symptoms 37 36







No significant changes 57 55
Meager intake with improvements or
borderline intake with deterioration
43 42
Hunger, inability to eat 3 3
Total 103 100
TABLE 3
SGA-AMOUNT (PERCENTAGE) OF WEIGHT LOSS
Number of patients %
No significant weight change 50 49
Weight loss of 5–10% 24 23
Weight loss of more than 10% 29 28
Total 103 100
TABLE 6
DAILY ACTIVITY PERFORMANCE STATUS
Number of patients %
No dysfunction 35 34
Mild dysfunction 40 39
Severe dysfunction 28 27
TABLE 7
NUTRITIVE DEMANDS CONSEQUENT TO DISEASE
COMPLICATIONS
Metabolic demands Number of patients %
Without 45 44









No abnormality detected (NAD) 51 49
Mild to moderate loss 38 37
Severe loss 14 14
Total 103 100
Discussion
The research results indicate that 60 patients (58%)
out of 103 patients did not eat enough due to decreased
appetite and, which is very alarming considering the fact
that appetite, weight loss and cachexia are often signs of
a malignant disease6,7. Also, 80 patients (78%) out of 103
patients have recently lost weight without trying. 31 of
80 patients or 39% have lost more than 10 kilograms,
which is significantly higher compared to a study where
only 6.5% of the patients lost more than 10 kilograms
(PG-SGA test used)16. Conversely, in a Norwegian study
82% of cancer patients (with an advanced disease) have
unintentionally lost weight and 63.15% have lost more
than 10 kilograms13. Weight loss of more than 10% is re-
lated to higher morbidity and mortality. Thus, in cancer
patients regular body mass measurement is an essential
element of healthcare13.
Total number of patients with changes in their diet
routine in our survey is 45% (of which 3% suffers from
hunger due to almost complete inability to eat and 42%
has moderate decrease in food intake). These numbers
match the results of some similar studies where appetite
problems were reported in 48–72% of the patients14,16,17.
Some authors recognized anorexia to be one of the main
problems in 42% of cancer patients16.
In 12 patients (12%), after nutrition screening of can-
cer patients with Malnutrition Screening Tool the MST
score was 5, and 18 patients (17%) had MST score 4. Ac-
cording to the diagram of procedure, both of the catego-
ries (MST 4 and 5) indicate the need for urgent introduc-
tion of enteral nourishment as well as a consult with
clinical nutrition specialist. 37 patients (35%) reached
MST score 2 or 3, which according to the procedure dia-
gram requires further clinical assessment of malnutri-
tion18.
Treatment modalities in oncology: surgery, chemo-
therapy and radiotherapy have negative influence on pa-
tient’s nutritional status, which is very variable depend-
ing on the individual treatment option9. In our survey,
based on the method of Subjective Global Assessment
(SGA) of the patients, 48% of the patients is well nour-
ished with normal parameters of nutritional assessment
(SGA A), 38% is moderately undernourished (SGA B),
while 14% of the patients suffers from severe undernour-
ishment (SGA C).
A study conducted on the Vukovar Health Center
Area showed that 26.09% had severe (SGA C), and
43.48% of the patients had moderate undernourishment
(SGA B). The same study showed that 19.23% of the pa-
tients used Ensure Plus, 11.54% used Megostat, 7,69%
used Prosure, 3.84% used some other product, while
57.7% of the patients didn’t7 use any additional products
as a nutritional support18. These facts indicate insuffi-
cient implementation of Croatian guidelines for the
treatment of tumor cachexia, taken into account that
megestrol-acetate and enteral high-protein nourishment
with increased intake of eicosapentaeonic acid (EPA),
have a proven positive effect on the appetite, calorie in-
take, body weight and feeling of well-being.
Other studies showed diverse results. A research from
Malaysia where patients treated at home have been
given PG-SGA questionnaire showed that more than
85% of the patients was moderately to severely under-
nourished19. Our research results are similar to results
reported by Segura et al.16 where 52% of the examinees
was undernourished (40.4% moderately and 11.8% se-
verely), as well as Bauer14, who found 75% of the patients
to be undernourished (59% moderately and 16% se-
verely). Montoya et al.20 carried out a research in a hospi-
tal on Philippines using SGA questionnaire. They found
47.7% of the cancer patients to be undernourished
(43.2% moderately and 4.5% severely). A Brazilian re-
search using SGA questionnaire discovered undernour-
ishment in 77.08% of cancer patients21 with similar re-
sults in an Australian study17: 76% of the patients were
undernourished according to SGA14.
Nutritional status considerably correlates with qual-
ity of life, psychophysical, functional and social/spiritual
domain of an individual19; patients with poor nutritive
status consequently have lower life quality17. An inter-
esting information from Segura’s study: 52% of the pati-
ents are moderately to severely undernourished, albeit
97.6% of the patients need some form or nutritional in-
tervention or consult16. It is important to educate cancer
patients and offer them more information and advice
about maintaining optimal food intake.
Some studies show that nutritional interventions sig-
nificantly improve individual nutritional status17. High
prevalence of malnutrition and cachexia in cancer pati-
ents treated at home after they underwent hospital
treatment who were enrolled in our research, indicates
the necessity of enteral nutritional support introduction
in all proven cases of malnutrition/cachexia. The type
and extent of the nutrition backup depend, apart from
the nourishment status (SGA category) and the nature of
the disease, on planned diagnostic and therapeutic proce-
dures, as well as on planned and anticipated length of
treatment22. A study with pancreatic cancer patients
showed that enrollment of nutritive and pharmacological
support results with transitory slower weight loss and in-
creased appetite23.
In this research 11 patients (11%) had everyday pres-
ence of 3 or more symptoms (fatigue, vomiting, diarrhea,
anorexia) in a period of more than 2 weeks, a duration
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TABLE 9





Well nourished (SGA A) 49 48
Moderately undernourished (SGA B) 39 38
Severely undernourished (SGA C) 15 14
Total 103 100
which is considered significant24. Pereira Borges et al.21
reported that 70% of cancer patients of one Brazilian
hospital had mentioned gastrointestinal symptoms. On
average, cancer patients experience 11 symptoms25.
Treating symptoms is one possible way for prevention of
malnutrition6,8,13.
To determine objective prevalence of malnutrition it
is important to obtain nutritional status of every patient,
which should include detailed personal history, prior
medication, physical, anthropometrical and biochemical
parameters6,8,10,13.
Conclusions
The research on the prevalence of malnutrition and
cachexia at the Osijek Health Center Area in patients
suffering from malignant diseases who are treated at
home has shown that 58% out of 103 patients ate mea-
gerly due to appetite loss, and 80 patients (78%) out of
103 patients lost weight without trying. Surprisingly, 31
out of 80 patients that lost weight (39%) have lost more
than 10 kilograms.
3% of the patients are suffering from hunger, 42%
have moderately decreased food intake. 27% suffer from
severe and 39% from moderate work dysfunction. 12% of
the patients are in need for enteral nutritional support
due to deterioration of the disease. 14% have severe loss
of subcutaneous fat tissue, and same amount of patients
have severe loss of musculature.
Based on the questionnaire results for the clinical as-
sessment of malnutrition in patients with a malignant
disease, 38% of patients are moderately undernourished
(SGA B) and 14% of patients are severely undernour-
ished (SGA C).
The research indicates the importance of early nutri-
tive screening of patients with a malignant disease, as
well as the assessment of their nutrition status and
higher presence of nutritive therapy, because in 31 pati-
ents (29%) after nutritive screening there was the need
for urgent implementation of enteral nutrition and nut-
rition consulting.
The application of the questionnaire in direct medical
practice has proved to be of great quality, simple, quick
and acceptable screening method of malnutrition and
cachexia in patients suffering from malignant diseases
with the final aim of introducing enteral nutrition as
early as possible, because that way we influence the im-
provement of the quality and prolongation of patients’
lives.
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OCJENA NUTRITIVNOG STATUSA KOD PACIJENATA OBOLJELIH OD RAKA NA
PODRU^JU DOMA ZDRAVLJA OSIJEK
S A @ E T A K
Cilj ovog istra`ivanja bio je izvr{iti prehrambeni probir i klini~ku procjenu malnutricije uzrokovane kaheksijom, kao
i potrebu za enteralnom prehranom. Koristili smo me|unarodni upitnik za probir prehrane i klini~ku procjenu pot-
hranjenosti. U istra`ivanju su sudjelovala 103 oboljela od raka. Rezultati pokazuju da je 80 bolesnika (78%) nedavno
nenamjerno izgubilo na tjelesnoj te`ini u posljednjih {est mjeseci. Od tih 80 bolesnika 12 (15%) ih je izgubilo vi{e od 15
kilograma. Tri bolesnika (3%) gladuju zbog nemogu}nosti uzimanja hrane. O postojanju 3 ili vi{e simptoma (mu~nina,
povra}anje, proljev ili anoreksija) se izjasnilo 11 bolesnika (11%). Te{ka radna disfunkcija je prona|ena je u 28 boles-
nika (27%). 14 bolesnika (14%) imalo je zna~ajan gubitak muskulature (m. kvadriceps femoris, m. deltoideus). Dobiveni
rezultati pokazuju da je 15 bolesnika (14%) te{ko, a 39 bolesnika (38%) umjereno pothranjeno. Ovo istra`ivanje potvr-
dilo je va`nost prehrambenog probira u pacijenata oboljelih od raka, budu}i da je otkriveno 30 bolesnika (29%) kod
kojih je potrebno uvo|enje enteralne prehrane.
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